Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03059472
Other study ID # IRB #: 1402004505-2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 31, 2017
Est. completion date February 28, 2019

Study information

Verified date January 2022
Source Cornell University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Strong Hearts for New York is a research study which aims to reduce cardiovascular disease (CVD), improve quality of life, and reduce CVD related health care costs in rural communities. Our aim is to better understand how changes in lifestyle can affect the health of rural women and others in their communities.


Description:

There are notable cardiovascular disease (CVD) disparities among people living in rural settings, particularly medically underserved rural areas. Complex factors such as socioeconomic disadvantage, social and cultural dynamics, geographic distances/barriers, and limited access to healthcare, healthy foods, and/or physical activity opportunities contribute to the issue. The objective of Strong Hearts, Healthy Communities (SHHC) is to reduce rural CVD disparities through civic engagement and implementation of a community-based intervention in 11 underserved New York communities. SHHC builds upon a long-standing collaboration with National Institute of Food and Agriculture cooperative extension educators, who will implement the project. There is limited knowledge about how programs and services can move beyond commonly used individual-level approaches-which have limitations in terms of cost, impact, reach, and sustainability-to effectively reduce rural CVD health disparities using an integrated, multi-level, community-engaged approach. The objective of Strong Hearts, Healthy Communities (SHHC) is to address this gap in knowledge and practice by working with residents, practitioners, health educators, local leadership, and other stakeholders in 11 medically underserved rural communities in New York to test a comprehensive program designed to: a) improve diet and physical activity behaviors, b) promote local built environment resources, and c) shift social norms about active living and healthy eating through civic engagement, capacity building, and community based programming. RANDOMIZED INTERVENTION AND DELAYED INTERVENTION: In the current phase of the project, the efficacy of the SHHC program curriculum will be evaluated in a 24-week delayed intervention trial. The investigators will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed communities in New York State. In addition, changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network" will be evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 182
Est. completion date February 28, 2019
Est. primary completion date February 28, 2019
Accepts healthy volunteers No
Gender Female
Age group 40 Years to 99 Years
Eligibility Inclusion Criteria: - Body Mass Index (BMI) greater than or equal to 25 - If BMI is less than 30, not currently physically active - Blood pressure is less than 160/100 mm Hg - Heart rate is between 60-100 bpm - English-speaking - Able and willing to obtain physician's approval to participate in intervention starting either in March 2017 or September 2017 - Willing to participate in assessment activities - Willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017 Exclusion Criteria: - BMI less than 25 - If BMI is less than 30, currently physically active - Untreated hypertension - Heart rate lower than 60 or higher than 100 bpm - Non-English speaking - Not able or willing to obtain physician's approval to participate - Not interested or willing to participate in assessment activities - Not able or willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017

Study Design


Intervention

Behavioral:
Group 1 (Intervention)
The investigators will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized delayed intervention trial. They will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed intervention communities. In addition, the investigators will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".
Group 2 (Delayed intervention)
The investigators will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized delayed intervention trial. They will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed intervention communities. In addition, the investigators will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".

Locations

Country Name City State
United States Clyde Clyde New York
United States Cobleskill Cobleskill New York
United States Cooperstown Cooperstown New York
United States Dolgeville and Little Falls Dolgeville New York
United States Hamilton Hamilton New York
United States Hartwick Hartwick New York
United States Herkimer, Mohawk and Ilion Herkimer New York
United States Ithaca Ithaca New York
United States Seguin Research Lab, Cornell University Ithaca New York
United States Milford Milford New York
United States Morrisville Morrisville New York
United States Newark Newark New York
United States Sharon Springs Sharon Springs New York

Sponsors (5)

Lead Sponsor Collaborator
Cornell University Bassett Healthcare, Cornell Cooperative Extension, Montana State University, Tufts University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body weight Baseline to 24 weeks
Secondary Changes in body weight Baseline to 48 weeks
Secondary Changes in blood pressure Baseline to 24 weeks, 48 weeks
Secondary Changes in blood lipids Baseline to 24 weeks, 48 weeks
Secondary Changes in c-reactive protein Baseline to 24 weeks, 48 weeks
Secondary Changes in hemoglobin A1C Baseline to 24 weeks, 48 weeks
Secondary Changes in waist circumference Baseline to 24 weeks, 48 weeks
Secondary Changes in hip circumference Baseline to 24 weeks, 48 weeks
Secondary Changes in 7 day accelerometry Baseline to 24 weeks, 48 weeks
Secondary Changes in 7 day dietary recall Baseline to 24 weeks, 48 weeks
Secondary Changes in healthy eating self-efficacy assessed by questionnaire Baseline to 24 weeks, 48 weeks
Secondary Changes in exercise self-efficacy assessed by questionnaire Baseline to 24 weeks, 48 weeks
Secondary Changes in healthy eating attitudes of social network of participants assessed by questionnaire Baseline to 24 weeks, 48 weeks
Secondary Changes in exercise attitudes of social network of participants assessed by questionnaire Baseline to 24 weeks, 48 weeks
Secondary Changes in healthy eating self-efficacy of social network of participants assessed by questionnaire Baseline to 24 weeks, 48 weeks
Secondary Changes in exercise self-efficacy of social network of participants assessed by questionnaire Baseline to 24 weeks, 48 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2